1. Home
  2. PTGX vs ENLT Comparison

PTGX vs ENLT Comparison

Compare PTGX & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • ENLT
  • Stock Information
  • Founded
  • PTGX 2006
  • ENLT 2008
  • Country
  • PTGX United States
  • ENLT Israel
  • Employees
  • PTGX N/A
  • ENLT N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • ENLT
  • Sector
  • PTGX Health Care
  • ENLT
  • Exchange
  • PTGX Nasdaq
  • ENLT Nasdaq
  • Market Cap
  • PTGX 3.3B
  • ENLT 2.7B
  • IPO Year
  • PTGX 2016
  • ENLT 2023
  • Fundamental
  • Price
  • PTGX $55.23
  • ENLT $24.75
  • Analyst Decision
  • PTGX Strong Buy
  • ENLT Buy
  • Analyst Count
  • PTGX 9
  • ENLT 4
  • Target Price
  • PTGX $67.11
  • ENLT $20.00
  • AVG Volume (30 Days)
  • PTGX 925.2K
  • ENLT 46.7K
  • Earning Date
  • PTGX 08-05-2025
  • ENLT 08-06-2025
  • Dividend Yield
  • PTGX N/A
  • ENLT N/A
  • EPS Growth
  • PTGX N/A
  • ENLT 90.47
  • EPS
  • PTGX 0.86
  • ENLT 0.98
  • Revenue
  • PTGX $207,801,000.00
  • ENLT $397,296,000.00
  • Revenue This Year
  • PTGX N/A
  • ENLT $355.90
  • Revenue Next Year
  • PTGX $53.09
  • ENLT $42.83
  • P/E Ratio
  • PTGX $63.67
  • ENLT $24.43
  • Revenue Growth
  • PTGX N/A
  • ENLT 44.42
  • 52 Week Low
  • PTGX $32.50
  • ENLT $14.01
  • 52 Week High
  • PTGX $60.60
  • ENLT $26.27
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.92
  • ENLT 63.75
  • Support Level
  • PTGX $49.38
  • ENLT $24.60
  • Resistance Level
  • PTGX $51.51
  • ENLT $26.27
  • Average True Range (ATR)
  • PTGX 2.09
  • ENLT 0.51
  • MACD
  • PTGX -0.14
  • ENLT 0.02
  • Stochastic Oscillator
  • PTGX 74.47
  • ENLT 58.81

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About ENLT Enlight Renewable Energy Ltd.

Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.

Share on Social Networks: